Award Year / Program / Phase:2009 / SBIR / Phase I
Agency:HHS
Principal Investigator:Allen B. Reitz
Award Amount:$600,000.00
Abstract:
DESCRIPTION (provided by applicant): One sixth of the world's population has an infectious disease, and new agents involving novel mechanisms less likely to engender resistance are needed if for no other reason than the almost certain emergence of mutant s
trains and new pathogens in the future.… More
DESCRIPTION (provided by applicant): Metastatic melanoma has few treatment options, and the current therapeutic standard of care is dacarbazine which is a highly cytotoxic drug with severe side effects including vomiting, headache and hair loss. Treatmentwith dacarbazine has a median… More